NodThera Announces Appointment of Chris Guiffre, J.D., M.B.A., as Chief Financial Officer
October 28, 2025
Boston, MA – NodThera, a clinical-stage biotech pioneering a paradigm shift in the treatment of chronic inflammatory diseases through NLRP3 inhibition, today announced the appointment of